Article: NO DELAY/Early or On Time Approval/1st To Market. post.
Seeking Alpha May 25,2012 By: Scott Matasow "5 Stock To Watch Next Week" Arena will have nice gains next week and it is my opinion that approval of Lorcaserin is a given at this point. Again, it does not seem to me that a REM will be required by the FDA, possibly making Lorcaserin the first doctor proscribed weight loss drug to hit the market since 1999. Arena to me is looking less like a speculative investment, and more like a long term winner. Keep a close eye on this one after a successful secondary offering was completed at $5.50 a share. This is a good time to buy Arena stock for the long haul in my opinion.
Again and again the articles keep coming from so so sources and reputable sources that "LORQ" will be approved, and first to market....I think wall street will have to catch on sooner then later...were looking better and better each day...I do believe we are in one of the blockbuster stocks of 2012. IMO